Life Sciences: How AI is Transforming Drug Discovery to Commercialization

Artificial intelligence is revolutionizing the life sciences industry, accelerating progress from drug discovery to commercialization. By harnessing vast datasets and advanced analytics, AI enables researchers to identify promising compounds, predict outcomes and optimize clinical trials with unprecedented speed and accuracy. In manufacturing and supply chain, AI streamlines operations, enhances quality control and improves forecasting. Commercial teams leverage AI-driven insights for targeted market strategies and personalized engagement. This session explores real-world applications and success stories, highlighting how AI is driving innovation, efficiency and better patient outcomes across the entire life sciences value chain.